—
C+
C+ The full Closelooknet — membership. Open the C+ overview

BeOne Medicines AG (ONC) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 65 out of 100 (momentum 91 · quality 64 · valuation 29), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +15.9% vs the 50-day and +29.8% vs the 200-day average, 0.2% below the 52-week high and +67% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes. (as of 2026-11-10)
  • Trend: BeOne Medicines AG trades 15.9% above its 50-day and 29.8% above its 200-day moving average. (as of 2026-11-10)

BeiGene, now renamed BeOne Medicines AG, is an oncology company that discovers and develops cancer treatments across the United States, China and Europe. Its marketed products include a BTK inhibitor for blood cancers, a PD-1 antibody used in solid tumours and blood cancers, and separate treatments for Castleman disease and certain breast and solid-tumour cancers, alongside a wide clinical pipeline of compounds targeting different cancer pathways and partnerships with several other pharmaceutical firms.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ONC overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +15.9% vs the 50-day and +29.8% vs the 200-day average, 0.2% below the 52-week high and +67% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the ONC chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on ONC?

Uptrend stack intact — Trades +15.9% vs the 50-day and +29.8% vs the 200-day average, 0.2% below the 52-week high and +67% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ONC above its 50-day and 200-day moving averages?

As of 2026-11-10, BeOne Medicines AG trades +15.9% above its 50-day and +29.8% above its 200-day average, with the 20-day +11.9% away.

How far is ONC from its 52-week high?

0.2% below the 52-week high and 67% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.